Background: The overexpression of sodium-glucose cotransporter 2 (SGLT2) in diabetic kidneys has been reported. It has also been established that the diabetic glomerular endothelium expresses the toll-like receptors TLR2 and TLR4. The present study aims to examine the renal SGLT2 induction by the TLR2/4 ligand Porphyromonas (P.) gingivalis lipopolysaccharide (Pg-LPS) in mouse diabetic nephropathy. Methods: Immunohistochemical study and tissue RT-PCR analyses were performed on mouse kidneys in streptozotocin (STZ)-induced diabetic ICR mice (STZ-ICR), in healthy ICR mice administered Pg-LPS (LPS-ICR), and in diabetic ICR mouse kidneys with Pg-LPS-induced nephropathy (LPS-STZ). Results: In the quantitative analysis of blood sugar levels, the...
Aim: SGLT2 inhibitors reduce renal glucose uptake through an insulin-independent mechanism. They als...
Activation of the renal transforming growth factor-β (TGF-β) system likely mediates the excess produ...
AIM: To quantify the expression of sodium-glucose co-transporter (SGLT)2 and SGLT1, their cognate ...
Background: The overexpression of sodium-glucose cotransporter 2 (SGLT2) in diabetic kidneys has bee...
Objective The present study aims to examine the expression of leukocyte adhesion molecules and renal...
The toll-like receptor (TLR) has been suggested as a candidate cause for diabetic nephropathy. Recen...
<p>(A) Tissue PCR for TLR2 mRNA of the mouse renal cortex. The RT-PCR and real-time PCR analysis sho...
Abstract Background Recently, we reported that toll-like receptor (TLR)2 and TLR4 localized on the g...
In individuals with diabetes, kidney size and glomerular filtration rate (GFR) tend to increase, and...
BACKGROUND: In the kidney glucose is freely filtered by the glomerulus and, mainly, reabsorbed by so...
Sodium/glucose cotransporter 2 (SGLT2) inhibitors are oral hypoglycemic agents used to treat patient...
Traditional treatments for type 1 and type 2 diabetes are often associated with side effects, includ...
What is the central question of this study? Although SGLT2 inhibitors represent a promising treatmen...
<p>(A) Immunohistochemistry for the expression of cytokines and podoplanin (PDPN) in glomeruli by la...
The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney disease (D...
Aim: SGLT2 inhibitors reduce renal glucose uptake through an insulin-independent mechanism. They als...
Activation of the renal transforming growth factor-β (TGF-β) system likely mediates the excess produ...
AIM: To quantify the expression of sodium-glucose co-transporter (SGLT)2 and SGLT1, their cognate ...
Background: The overexpression of sodium-glucose cotransporter 2 (SGLT2) in diabetic kidneys has bee...
Objective The present study aims to examine the expression of leukocyte adhesion molecules and renal...
The toll-like receptor (TLR) has been suggested as a candidate cause for diabetic nephropathy. Recen...
<p>(A) Tissue PCR for TLR2 mRNA of the mouse renal cortex. The RT-PCR and real-time PCR analysis sho...
Abstract Background Recently, we reported that toll-like receptor (TLR)2 and TLR4 localized on the g...
In individuals with diabetes, kidney size and glomerular filtration rate (GFR) tend to increase, and...
BACKGROUND: In the kidney glucose is freely filtered by the glomerulus and, mainly, reabsorbed by so...
Sodium/glucose cotransporter 2 (SGLT2) inhibitors are oral hypoglycemic agents used to treat patient...
Traditional treatments for type 1 and type 2 diabetes are often associated with side effects, includ...
What is the central question of this study? Although SGLT2 inhibitors represent a promising treatmen...
<p>(A) Immunohistochemistry for the expression of cytokines and podoplanin (PDPN) in glomeruli by la...
The incidence of type 2 diabetes (T2D) has been increasing worldwide, and diabetic kidney disease (D...
Aim: SGLT2 inhibitors reduce renal glucose uptake through an insulin-independent mechanism. They als...
Activation of the renal transforming growth factor-β (TGF-β) system likely mediates the excess produ...
AIM: To quantify the expression of sodium-glucose co-transporter (SGLT)2 and SGLT1, their cognate ...